Ambient AI for Provider Well-Being

May 28, 2025 updated by: University of Wisconsin, Madison

An EHR-embedded Pragmatic Stepped-wedge Individual Randomized Clinical Trial of Ambient Artificial Intelligence to Improve Provider Well-Being

The goal of this clinical trial is to learn whether using Ambient Artificial Intelligence for provider documentation will enhance provider well-being and improve documentation quality.

Participants will complete their documentation using the Ambient AI software.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Provider documentation of patient visits is a time-consuming activity that extends throughout the workday and often continues outside office hours. This ongoing clerical burden negatively impacts provider well-being, contributing to burnout and job dissatisfaction.

To address these challenges, the researchers propose to test the effectiveness of the Ambient AI tool in improving provider fulfillment and note documentation efficiency. The overarching goal is to leverage AI technology to enhance provider well-being and documentation quality.

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wisconsin
      • Madison, Wisconsin, United States, 53705
        • University of Wisconsin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthcare Provider in the UW Health Outpatient Clinic Setting
  • Willingness to engage and use ambient technology
  • Owns an Apple mobile device, as the software is accessible only on this platform
  • Adult (greater than 18 years)
  • English or Spanish speaking
  • Completed the training and in-servicing required to use the tool
  • Providing outpatient care to no less than 20 encounters on a weekly average

Exclusion Criteria:

  • Planned leave in 6 weeks following randomization
  • Not registered onto Epic's mobile Haiku system for access
  • Enrolled in a virtual scribe program and not willing to leave the program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ambient Listening Group 1
Participants randomized to this arm will start using Ambient AI at week 7.
Ambient AI software intervention is implemented into the providers workflow. The software incorporates Automated Speech Recognition technology with Large Language Models to generate clinical documentation in real-time.
Experimental: Ambient Listening Group 2
Participants randomized to this arm will start using Ambient AI at week 13.
Ambient AI software intervention is implemented into the providers workflow. The software incorporates Automated Speech Recognition technology with Large Language Models to generate clinical documentation in real-time.
Experimental: Ambient Listening Group 3
Participants randomized to this arm will start using Ambient AI at week 19.
Ambient AI software intervention is implemented into the providers workflow. The software incorporates Automated Speech Recognition technology with Large Language Models to generate clinical documentation in real-time.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in provider fulfillment index
Time Frame: Baseline to weeks 6, 12, 18, and 24
Using the Professional Well-Being Academic Consortium Survey Measures, the fulfillment index is a 6-item questionnaire. Each question is scored on a 0-4 Likert scale, with total possible scores of 0-24. Higher scores indicate greater fulfillment
Baseline to weeks 6, 12, 18, and 24
Change in provider burnout
Time Frame: Baseline to weeks 6, 12, 18, and 24
Using the Professional Well-Being Academic Consortium Survey Measures, the burnout index includes two subcomponents of work exhaustion and interpersonal disengagement. It is a 10-item questionnaire, scored together as a composite. Each question is scored on a 0-4 Likert scale, with a total possible range of 0-40. Higher scores indicate greater burnout, indicating lower well-being
Baseline to weeks 6, 12, 18, and 24

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in time spent on documentation outside work hours
Time Frame: Baseline to 24 weeks
Providers will track amount of time spent on EHR (electronic health records) outside of scheduled patient hours per 8 hours of patient scheduled time
Baseline to 24 weeks
Change in task load
Time Frame: Baseline to 24 weeks
Hours spent on documentation per 8 hours of scheduled patient time
Baseline to 24 weeks
Change in meaningfulness of work
Time Frame: Baseline to 24 weeks
Meaningfulness of work is a 4-item questionnaire, where each question is scored on a 0-4 Likert scale. Total possible scores range from 0-16, with higher scores indicating lower sense of meaningfulness of work.
Baseline to 24 weeks
Change in meaningful relationships
Time Frame: Baseline to 24 weeks
Using the Professional Well-Being Academic Consortium Survey Measures, the negative impact of work on relationships index is a 4-item questionnaire. Each question is scored on a 0-4 Likert scale, with total possible scores ranging from 0-16. Higher scores indicate less meaningful relationships.
Baseline to 24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Majid Afshar, MD, MS, University of Wisconsin, Madison
  • Principal Investigator: Joel Gordon, MD, University of Wisconsin, Madison

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2024

Primary Completion (Actual)

March 27, 2025

Study Completion (Actual)

March 27, 2025

Study Registration Dates

First Submitted

July 18, 2024

First Submitted That Met QC Criteria

July 18, 2024

First Posted (Actual)

July 24, 2024

Study Record Updates

Last Update Posted (Actual)

May 30, 2025

Last Update Submitted That Met QC Criteria

May 28, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-1028
  • A534285 (Other Identifier: UW Madison)
  • Protocol Version 7/7/2024 (Other Identifier: UW- Madison)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

As part of the UW Learning Health System, the data queries, data dictionary, and data procedure will be mirrored over from the UW Health GitHub instance to SMPH GitLab instance for secondary research use. All patient data except timestamps will be deidentified (limited dataset) and managed and stored on SMPH servers and devices and provided through Clinical Research Data Service (CRDS) team in ICTR's Center for Health Informatics Institute and the UW SMPH Honest Broker. Provider data will be stored with identifiers for the follow-up focus groups and interviews.

IPD Sharing Time Frame

Duration of storage will be at least 10 years.

IPD Sharing Access Criteria

Access to data and recordings and security measures will require IRB approval and request through CRDS.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthcare Provider Well-being

Clinical Trials on Artificial Intelligence

Subscribe